Insights

Production-Ready Seed Phylos focuses on Production-Ready Seed products including premium, phenotypically stable, fully-feminized F1 hybrid seeds that deliver high flower quality, potency, vigor, and yield, presenting a key upsell for large-scale cultivators seeking reliable genetics and cost-effective cultivation.

Strategic Partnerships Recent and ongoing partnerships with ILGM, Organigram, and collaborations like Galaxy and genotype testing create multiple cross-sell opportunities for expanded distribution, integrated seed and genetics services, and data-driven cultivation solutions.

THCV and Clinical Research Phylos strong emphasis on THCV genetics and clinical research programs opens sales avenues with research-oriented cultivators and product developers seeking unique cannabinoid profiles and scientifically validated ingredients.

Leadership and Growth Appointment of a Chief Commercial Officer and a trajectory of commercial expansion signals heightened focus on go-to-market execution, sales operations, and scaling distribution channels to grow revenue from mid-market to larger producer segments.

Digital and CRM Backbone Utilization of a broad tech stack including Salesforce, Shopify, Freshdesk, Asana, and Jira indicates readiness for scalable sales, e-commerce, customer support, and project management to support enterprise accounts and partner onboarding.

Similar companies to Phylos

Phylos Tech Stack

Phylos uses 8 technology products and services including QuickBooks, Canva, Salesforce, and more. Explore Phylos's tech stack below.

Media & News

Phylos's Email Address Formats

Phylos uses at least 3 email formats:
Phylos Email FormatsExamplePercentage
FLast@phylos.bioJDoe@phylos.bio
92%
First@phylos.bioJohn@phylos.bio
5%
FirstLast@phylos.bioJohnDoe@phylos.bio
3%

Frequently Asked Questions

What is Phylos's official website and social media links?

Minus sign iconPlus sign icon
Phylos's official website is phylos.bio and has social profiles on LinkedIn and Crunchbase.

How much revenue does Phylos generate?

Minus sign iconPlus sign icon
As of August 2026, Phylos's annual revenue is estimated to be $10M - $25M.

What is Phylos's SIC code and NAICS code?

Minus sign iconPlus sign icon
Phylos's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Phylos have currently?

Minus sign iconPlus sign icon
As of August 2026, Phylos has approximately 48 employees across 3 continents, including North America, Oceania and Europe. Key team members include Chief Executive Officer: L. S., Vice President Of Research And Development: J. K. and Vice President Of Marketing: P. H. Explore Phylos's employee directory with LeadIQ.

What industry does Phylos belong to?

Minus sign iconPlus sign icon
Phylos operates in the Biotechnology Research industry.

What technology does Phylos use?

Minus sign iconPlus sign icon
Phylos's tech stack includes QuickBooks, Canva, Salesforce, Shopify, Freshworks Freshdesk, Asana, Atlassian Jira and Adobe Creative Suite.

What is Phylos's email format?

Minus sign iconPlus sign icon
Phylos's email format typically follows the pattern of FLast@phylos.bio. Find more Phylos email formats with LeadIQ.

How much funding has Phylos raised to date?

Minus sign iconPlus sign icon
As of August 2026, Phylos has raised $20M in funding. The last funding round occurred on Dec 31, 2025 for $1.8M.

When was Phylos founded?

Minus sign iconPlus sign icon
Phylos was founded in 2014.
Phylos logo

Phylos

Biotechnology ResearchOregon, United States11-50 Employees

Phylos is a cannabis genetics company operating within the biotechnology research sector, based in Portland, Oregon. It develops production-ready seeds designed for commercial cultivation, offering fully feminized F1 hybrid lines that are phenotypically stable and intended to deliver high-quality flowers, strong vigor, and reliable yields. Its products target growers of various sizes seeking dependable genetics and cost-efficient production. 

Its work encompasses THCV genetics and related ingredients, supported by cultivation, extraction, and formulation capabilities. In April 2024, Phylos and ILGM announced an exclusive partnership to introduce 15 new F1 hybrid strains to U.S. cannabis consumers.

Section iconCompany Overview

Website
phylos.bio
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $20M

    Phylos has raised a total of $20M of funding over 9 rounds. Their latest funding round was raised on Dec 31, 2025 in the amount of $1.8M as a Convertible Note.

  • $10M - $25M

    Phylos's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.